THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 91 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,610,000 | -6.0% | 144,619 | +6.9% | 0.01% | -16.7% |
| Q3 2016 | $4,902,000 | +59.5% | 135,265 | -0.1% | 0.01% | +50.0% |
| Q2 2016 | $3,073,000 | +43.0% | 135,449 | +18.5% | 0.00% | +33.3% |
| Q1 2016 | $2,149,000 | +27.8% | 114,300 | +11.4% | 0.00% | +50.0% |
| Q4 2015 | $1,681,000 | +57.5% | 102,583 | +5.7% | 0.00% | +100.0% |
| Q3 2015 | $1,067,000 | -15.9% | 97,093 | -0.4% | 0.00% | -50.0% |
| Q2 2015 | $1,269,000 | +5.9% | 97,491 | +41.1% | 0.00% | 0.0% |
| Q1 2015 | $1,198,000 | +17.2% | 69,071 | +0.9% | 0.00% | +100.0% |
| Q4 2014 | $1,022,000 | -35.8% | 68,488 | -0.8% | 0.00% | -50.0% |
| Q3 2014 | $1,591,000 | -27.4% | 69,013 | +0.4% | 0.00% | -33.3% |
| Q2 2014 | $2,190,000 | – | 68,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
| Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
| Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
| Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
| Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
| CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
| Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
| King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
| Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
| PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |